HRLCX
Price
$8.24
Change
-$0.00 (-0.00%)
Updated
Jan 17 closing price
Net Assets
75.37M
RIRBX
Price
$70.01
Change
+$0.35 (+0.50%)
Updated
Jan 17 closing price
Net Assets
106.42B
Ad is loading...

HRLCX vs RIRBX

Header iconHRLCX vs RIRBX Comparison
Open Charts HRLCX vs RIRBXBanner chart's image
Hartford Real Asset C
Price$8.24
Change-$0.00 (-0.00%)
VolumeN/A
Net Assets75.37M
American Funds Capital Income Bldr R2
Price$70.01
Change+$0.35 (+0.50%)
VolumeN/A
Net Assets106.42B
HRLCX vs RIRBX Comparison Chart
Loading...
View a ticker or compare two or three
VS
HRLCX vs. RIRBX commentary
Jan 19, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is HRLCX is a Hold and RIRBX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
RIRBX has more cash in the bank: 106B vs. HRLCX (75.4M). HRLCX pays higher dividends than RIRBX: HRLCX (3.25) vs RIRBX (2.55). HRLCX was incepted earlier than RIRBX: HRLCX (15 years) vs RIRBX (23 years). HRLCX is a more actively managed with annual turnover of: 171.00 vs. RIRBX (106.00). RIRBX has a lower initial minimum investment than HRLCX: RIRBX (250) vs HRLCX (2000). RIRBX annual gain was more profitable for investors over the last year : 9.89 vs. HRLCX (4.11). RIRBX return over 5 years is better than : 19.51 vs. HRLCX (18.28).
HRLCXRIRBXHRLCX / RIRBX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence15 years23 years-
Gain YTD2.8711.405204%
Front LoadN/AN/A-
Min. Initial Investment2000250800%
Min. Initial Investment IRAN/AN/A-
Net Assets75.4M106B0%
Annual Yield % from dividends3.252.55127%
Returns for 1 year4.119.8942%
Returns for 3 years3.625.6564%
Returns for 5 years18.2819.5194%
Returns for 10 years24.4930.0981%
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
PTCT43.840.76
+1.76%
PTC Therapeutics
CBAN15.840.22
+1.41%
Colony Bankcorp Inc
ABCL2.970.03
+1.02%
AbCellera Biologics
PAVM0.650.01
+0.81%
PAVmed
EXPE187.28-1.39
-0.74%
Expedia Group